Founded in 2007, the TTS Global Initiative is the premier international platform bringing together critical opinions from all stakeholders groups involved in the early stage biotechnology healthcare sector.

The TTS Global Initiative has one primary objective: to foster innovation by accelerating the translation of world-class life sciences and biomedical research from the lab to the patient and the market.

The TTS Global Initiative revolves around one central principal; that the best way to foster innovation is to bring together decision-makers to debate and deliberate the challenges and engage in high-quality networking, deal making and business development.

Mission:
To provide a platform for engagement and business development across the entire biotech innovation value chain. To create a more efficient and informed sector – one challenged and invigorated by serious deliberation and a deeper understanding of their sector, stakeholder, markets and key drivers.

Vision:
Their vision is nothing less than realizing and accelerating the full potential of biotechnology innovation – to improve access to research and innovation, to drive a new era of development, growth, and ultimately socio-economic benefit.